Castrate Resistant Prostate Cancer Enhertu Therapy

Clinical trial NCT06610825 · RECRUITING

Trial details

NCT number: NCT06610825
Sponsor: Washington D.C. Veterans Affairs Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Prostate Cancer CRPC

Start date: 2025-03-05
Primary completion: 2027-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.